These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 984522)

  • 1. [Clinical and anatomopathologic effect of Bisolvon in respiratory resuscitation].
    Racle JP; Girard M; Delage J; Constantin B
    Ann Anesthesiol Fr; 1976; 17(1):51-8. PubMed ID: 984522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental studies on the question of an adjuvant function of bromhexine].
    GOtz VH
    Arzneimittelforschung; 1975 Apr; 25(4):607-15. PubMed ID: 808230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Viscosimetric studies on the effectiveness of a postoperative bronchial secretolytic agent].
    Heil T; Mattes P; Braun S
    Chir Forum Exp Klin Forsch; 1979; ():265-7. PubMed ID: 456137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Round table. Relevant controls and usefulness of treatments modifying bronchial secretions (author's transl)].
    Bull Physiopathol Respir (Nancy); 1973; 9(2):417-71. PubMed ID: 4778961
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a secretolytic agent (bromhexine) on the penetration of erythromycin into bronchial secretions].
    Bergogne-Berezin E; Pierre J; Dournovo P
    Fortschr Med; 1982 Jun; 100(24):1169-71. PubMed ID: 7049878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of ambroxol and bromhexine on the "respiratory burst" of alveolar macrophages].
    Winsel K; Grollmuss H; Unger U; Renner H
    Pharmazie; 1986 Nov; 41(11):796-9. PubMed ID: 3104935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bromhexine (Bisolvon). An evaluation from the literature].
    Kampmann JP
    Ugeskr Laeger; 1974 Jul; 136(31):1757-9. PubMed ID: 4605541
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
    Braga PC; Bossi R; Allegra L
    Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bromhexine hydrochloride on the viscoelastic properties of mucus from the mini-pig.
    Martin GP; Loveday BE; Marriott C
    Eur Respir J; 1990 Apr; 3(4):392-6. PubMed ID: 2365032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flegamin - Polish equivalent of bisolvon. Results of clinical studies].
    Owsiński J; Ciezarek M; Kamińska M; Lukasiewicz W; Maternowska W; Walaszek K; Nikodemowicz E
    Pol Tyg Lek; 1980 Mar; 35(12):449-51. PubMed ID: 7383936
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methods of experimental study of modifier of bronchial secretions].
    Quevauviller A; Huyen VN; Garcet S
    Poumon Coeur; 1970; 26(1):71-80. PubMed ID: 4192772
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The short-term clinical evaluation of bromhexine in chronic bronchitis.
    Palmer KN
    Scand J Respir Dis Suppl; 1974; 90():65-8. PubMed ID: 4618375
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions.
    Bergogne-Bérézin E; Berthelot G; Kafé HP; Dournovo P
    Int J Clin Pharmacol Res; 1985; 5(5):341-4. PubMed ID: 4066084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mucolytic acitivity of bromhexine guaiacol combination in chronic bronchopneumopathy patients].
    Clini V; Guadagni L; Zennaro M; Fumagalli G
    G Clin Med; 1979 Jun; 60(6):475-89. PubMed ID: 381086
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modulation of alveolar macrophage activity by ambroxol, bromhexine and exogenous arachidonic acid].
    Winsel K; Grollmuss H; Unger U; Eckert H
    Z Erkr Atmungsorgane; 1985; 165(2):149-62. PubMed ID: 3002048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of the possible influence of a fluidifying agent (bromhexine) on the penetration of erythromycine into bronchial secretions (author's transl)].
    Bergogne-Berezin E; Pierre J; Dournovo P
    Therapie; 1979; 34(6):705-11. PubMed ID: 547444
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in the fibre system and viscosity of the sputum of bronchitis during treatment with bromhexine and guaiphenesin (guaiacol glyceryl ether).
    Bürgi H
    Scand J Respir Dis Suppl; 1974; 90():81-5. PubMed ID: 4618378
    [No Abstract]   [Full Text] [Related]  

  • 20. The principles of drug action on cough and on sputum characteristics.
    Richardson PS
    Eur J Respir Dis Suppl; 1980; 110():67-79. PubMed ID: 6938393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.